Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease
International Journal of Molecular Sciences · 28.05.2026 · 27 (11) · 4872
DOI: 10.3390/ijms27114872 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.05.2026. Verfasst von Jerome Lian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Therapeutic Sciences and Curtin Medical Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA 6102, Australia. Hauptthemen laut MEDLINE: Diet, Western, Cannabinoids, Liver Diseases, Metabolic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Diagnostic and Therapeutic Sciences and the Curtin Medical Research Institute, Curtin Un, LIPOVEXA S.r.l, School of Diagnostic and Therapeutic Sciences and the Curtin Medical Research Institute, Curtin University.
Abstract (Originalsprache)
Pharmacological treatment of metabolic-dysfunction-associated steatohepatitis remains challenging due to its complex pathophysiology. The endocannabinoidome (eCB) has emerged as a promising therapeutic target given its central role in energy homeostasis and its pharmacological tractability. Western-style diets high in fat and sugar exacerbate metabolic liver disease, highlighting the need for effective interventions. Here, we investigated the therapeutic potential of cannabinoid combinations targeting the eCB–liver axis in a Western diet-induced model of metabolic dysfunction. Two weeks of treatment reduced body weight, improved glycaemic control, and ameliorated liver pathology. These effects were accompanied by decreased liver weight, improved liver enzyme profiles, and reduced histological features of steatosis and injury. Overall, these findings suggest that modulation of the eCB system can induce acute improvements in metabolic and hepatic parameters under conditions of diet-induced metabolic stress. These results support further investigation into the eCB system as a therapeutic target, particularly to elucidate underlying mechanisms and longer-term effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diagnostic and Therapeutic Sciences and Curtin Medical Research Institute, Faculty of Health Sciences, Curtin University, Perth, WA 6102, Australia.
- Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Perth, WA 6000, Australia.
- Department of Medicine and Surgery, University of Parma, Via Volturno 39, 43125 Parma, Italy.
ORCID-Profile: Mohan Patil, Ricky R Lareu, Marco Falasca
Förderung
- School of Diagnostic and Therapeutic Sciences and the Curtin Medical Research Institute, Curtin Un
- LIPOVEXA S.r.l
- School of Diagnostic and Therapeutic Sciences and the Curtin Medical Research Institute, Curtin University
Zitieren
APA
Lian, J., Patil, M., Lareu, R. R., & Falasca, M. (2026). Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease. International Journal of Molecular Sciences, 27(11), 4872. https://doi.org/10.3390/ijms27114872
Vancouver
Lian J, Patil M, Lareu RR, Falasca M. Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease. International Journal of Molecular Sciences. 2026;27(11):4872. doi:10.3390/ijms27114872
BibTeX
@article{Lian2026,
author = {Lian, Jerome and Patil, Mohan and Lareu, Ricky R and Falasca, Marco},
title = {Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4872},
doi = {10.3390/ijms27114872}
}
EUVIMED